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The myeloid differentiation primary response gene
88 (Myd88) is critical for protection against patho-
gens. However, we demonstrate here that MyD88
expression in B cells inhibits resistance of mice to
Salmonella typhimurium infection. Selective defi-
ciency ofMyd88 in B cells improved control of bacte-
rial replication and prolonged survival of the infected
mice. The B cell-mediated suppressive pathway was
even more striking after secondary challenge. Upon
vaccination, mice lacking Myd88 in B cells became
completely resistant against this otherwise lethal
infection, whereas control mice were only partially
protected. Analysis of immune defenses revealed
that MyD88 signaling in B cells suppressed three
crucial arms of protective immunity: neutrophils,
natural killer cells, and inflammatory T cells. We fur-
ther show that interleukin-10 is an essential mediator
of these inhibitory functions of B cells. Collectively,
our data identify a role for MyD88 and B cells in regu-
lation of cellular mechanisms of protective immunity
during infection.
INTRODUCTION
B lymphocytes can produce antibodies, present antigen to
T cells, and secrete cytokines. The production of antibodies is
usually induced upon triggering of the B cell receptor (BCR) by
antigen and provision of costimulatory signals from T helper
lymphocytes. Accordingly, defects in BCR signaling or in T cell
help can result in antibody deficiencies and increased suscepti-
bility to infections (Conley et al., 2009). B cells can also be acti-Ivated directly by microbial products through Toll-like receptors
(TLRs) and the adaptor protein encoded by myeloid differentia-
tion primary response gene 88 (Myd88). However, the role of
intrinsic MyD88 signaling in B cells during bacterial infections
is not yet well defined.
TLR agonists can increase antibody responses, suggesting
a role for TLRs in humoral immunity (Krieg, 2007). Indeed,
Myd88/ mice fail to generate bone marrow (BM) plasma cells
and to maintain long-term humoral immunity after infection with
polyoma virus (Guay et al., 2007). Similarly, neutralizing antibody
titers rapidly decline in Myd88/ mice infected with vesicular
stomatitis virus, as compared to wild-type mice (Zhou et al.,
2007). These effects may result from a lack of TLR signaling in
B cells. B cells are known to express TLRs, and TLR agonists
can induce their proliferation and secretion of antibodies in vitro
(Gururajan et al., 2007; Krieg et al., 1995). Furthermore, B cell-
deficient mice reconstituted with Myd88-deficient B cells make
weaker antibody responses than mice with wild-type B cells
when lipopolysaccharide (LPS) is used as adjuvant (Meyer-Bahl-
burg et al., 2007). Myd88-deficient B cells also produce fewer
specific antibodies than wild-type B cells in mixed BM chimera
infected with a herpes virus (Gargano et al., 2008). However,
other studies found that mice with Myd88-deficient B cells can
mount normal primary antibody responses after immunization
with certain adjuvants, suggesting that this pathway differently
contributes to antibody responses depending on the type of
immunechallenge (Gavin et al., 2006; Lampropoulou et al., 2008).
TLRs can also stimulate antibody-independent functions of
B cells, including cytokine production. B cells can secrete inter-
leukin (IL)-10, and thereby suppress autoimmune diseases such
as experimental autoimmune encephalomyelitis (EAE), experi-
mental ulcerative colitis, and collagen-induced arthritis (Filla-
treau et al., 2002;Mauri et al., 2003;Mizoguchi et al., 2002). Simi-
larly, human B cells can produce IL-10 and inhibit autoimmune
pathology (Duddy et al., 2007; Duddy et al., 2004; Goetz et al.,
2007). Remarkably, TLRs can initiate the production of IL-10mmunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc. 777
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Figure 1. Ablation of Myd88 in B Cells
Improves Survival of Mice Infected with
Virulent Salmonella
Mice were infected intravenously (i.v.) with 100
CFU virulent Salmonella typhimurium (SL1344).
(A) Survival of C57BL/6 (n = 15) and Myd88/
(n = 14) mice after infection.
(B) Survival of B-WT (n = 17) and B-Myd88/
(n = 17) mice after infection.
(C) Survival of B-WT (n = 8) and B-Tlr2/Tlr4/
(n = 10) mice after infection
(D) Survival of C57BL/6 (n = 15) and C57BL/6 mice
treated i.v. with 200 mg anti-CD25 antibody 3 days
prior to infection (n = 12).
See also Figure S1.
Immunity
Suppressive Roles of MyD88 Signaling in B Cellsby naive B cells and are essential for the regulatory functions of B
cells in EAE (Lampropoulou et al., 2008). Thus, mice with B cell-
specific deficiency in both Tlr2 and Tlr4 or in Myd88 develop
a chronic form of EAE, similar to mice with Il10-deficient B cells,
whereasmicewith wild-type B cells recover after a short episode
of paralysis (Fillatreau et al., 2002; Lampropoulou et al., 2008).
The function of MyD88 signaling in B cells during bacterial
infection is poorly understood. This signaling may lead to
increased presentation of antigen to T cells and/or to augmented
production of protective antibodies, so that deletion ofMyd88 in
B cells may impair resistance to infections. Alternatively, the
recently identified role of MyD88 in the suppressive functions
of B cells in EAE (Lampropoulou et al., 2008) suggests that abla-
tion ofMyd88 specifically in B cells could unleash cell-mediated
immune responses and improve protection against pathogens.
Here, we addressed the specific role of MyD88 signaling in
B cells in mice during Salmonella typhimurium infection. Salmo-
nella are facultative intracellular Gram-negative bacteria that can
cause a wide range of diseases. In mice S. typhimurium induces
a disease with similarities to typhoid fever, which in humans
causes 600,000 deaths annually (Mittru¨cker and Kaufmann,
2000; Pang et al., 1998). We found that selective deficiency of
Myd88 in B cells strongly improved resistance of mice against
S. typhimurium infection. Thus, one of the major consequences
of MyD88 signaling in B cells is the counter-regulation of protec-
tive immunity during infection by such intracellular bacteria.
RESULTS
Ablation of Myd88 in B Cells Improves Survival
of Salmonella-Infected Mice
The role of MyD88 in B cells was assessed in chimera mice
in which only B cells lack Myd88 (B-Myd88/). To produce
B-Myd88/ mice, B cell-deficient JHT mice were lethally irradi-
ated and reconstituted with a mixture of BM cells from JHT
(80%) and Myd88/ mice (20%). In such chimera, all B cells778 Immunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc.(B
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The advantage of this experimental
system is the absence of leakiness; that
is, no wild-type B cells can be found
in B-Myd88/ chimera. Control mice
-WT) were generated by reconstituting irradiated JHT mice
ith BM cells from C57BL/6 (80%) and Myd88/ (20%) mice.
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on of these chimera revealed that their immune systems were
omparable, except for a mild decrease in frequency of follicular
cells and increases in frequencies of marginal zone and
D1dhiCD5+ B cells in B-Myd88/ mice compared to B-WT
ice (Figure S1A available online). Activation status of B cells,
D11c+ dendritic cells (DCs), CD11b myeloid cells, and T cells
ere similar in the two types of mice (Figures S1B and S1C).
To address the role of MyD88 in host protection, we first
fected Myd88/ and C57BL/6 mice via the intravenous (i.v.)
ute with virulent S. typhimurium (strain SL1344) and monitored
eir survival. Mice with completeMyd88 deficiency succumbed
S. typhimurium infection earlier thanC57BL/6mice (Figure 1A).
e then specifically examined the role of MyD88 signaling in B
ells by infecting B-Myd88/ and B-WT mice in the same
ay. Remarkably, lack of Myd88 expression by B cells resulted
prolonged survival of the infected mice (Figure 1B). B-WT
ice started to die on day 6 postinfection (p.i.) and all had
uccumbed by day 9 with a median survival time of 8 days (Fig-
re 1B). In contrast, B-Myd88/ mice started to die at day 10
nd survived until day 13 with a median survival time of
2 days (Figure 1B). Thus,Myd88 deficiency in B cells extended
urvival time by 4 days. These results demonstrate the dual
le of MyD88 in host defense: expression of MyD88 in cells
ther than B cells promotes the survival of infected mice,
hereas its expression in B cells counterbalances this protective
ffect. Similarly, mice lacking both Tlr2 and Tlr4 in B cells
-Tlr2/Tlr4/) displayed prolonged survival upon infection
ith Salmonella compared to B-WT mice (Figure 1C), suggest-
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Figure 2. Myd88 Deficiency in B Cells
Improves Control of Salmonella Infection
(A) Bacterial loads in spleen (top) and liver (bottom)
of B-WT (black square) and B-Myd88/
(white square) mice after infection with SL1344
(n = 8–10 mice per group per time point).
(B) Serum titers of alanine aminotransferase
(ALT; top) and aspartate aminotransferase (AST;
bottom) in infected B-WT (black bars) and
B-Myd88/ mice (white bars).
(C) Liver histochemistry of total infiltrating cells
(hematoxylin and eosin [H&E]), macrophages
(F4/80), neutrophils (MPO7; myeloperoxidase 7),
T cells (CD3), and B cells (B220) at day 6 p.i. A
1003magnification of the original image is shown.
(D) Number of the inflammatory foci per liver
section at day 6 p.i. (B-WT, n = 5; B-Myd88/,
n = 6).
(A–D) Results shown are pooled from two indepen-
dent experiments. Means ± SEM. *p < 0.05; **p <
0.01; ***p < 0.0001.
Immunity
Suppressive Roles of MyD88 Signaling in B Cellsmicrobial sensing by the B cells. To address whether natural
regulatory CD4+CD25+ T (Treg) cells also limit host protection
to S. typhimurium, we treated C57BL/6 mice with aCD25 anti-
body 3 days before infection, given that such treatment was
shown to impair the suppressive functions of Treg cells (Ste-
phens and Anderton, 2006). Indeed, we observed complete
disappearance of CD4+CD25+ T cells from peripheral blood
within 3 days (data not shown), but this had no effect on the
survival of infected mice (Figure 1D). These data highlight the
unique role of B cells in the regulation of host protection during
systemic S. typhimurium infection.
Although the functions of MyD88 in promoting host defense to
pathogens have been extensively investigated, the specific
effects resulting fromMyD88-signaling in B cells during infection
are poorly defined. Thus, we analyzed how the lack of Myd88
in B cells could improve protection. The longer survival of
B-Myd88/mice correlated with lower bacterial loads in spleen
and liver as compared to B-WT mice (Figure 2A). At day 4 p.i.,
B-WT mice carried a 10-fold greater bacterial burden in spleen
and liver than B-Myd88/ mice, and this difference reachedImmunity 33, 777–790, N100-fold by day 6, implying that expres-
sion of MyD88 in B cells impaired control
of the infection (Figure 2A). This increased
bacterial load correlated with higher
liver tissue damage in B-WT mice than
in B-Myd88/ mice, as revealed by
serum amounts of alanine aminotrans-
ferase (ALT) and aspartate aminotrans-
ferase (AST) at day 6 p.i. (Figure 2B).
We then addressed whether MyD88
signaling in B cells suppressed the
immune response to bacteria by perform-
ing histological analyses in infected livers.
At day 6 p.i., livers contained inflamma-
tory foci consisting of F4/80+ macro-
phages, MPO7+ neutrophils, and CD3+
T cells (Figure 2C). Low numbers of
B cells were found in the periphery ofthese foci and in adjacent portal tracts (Figure 2C). Remarkably,
livers from B-Myd88/ mice had 2-fold more inflammatory
foci than livers from B-WT mice, indicating that MyD88 signaling
in B cells suppressed local immune protection in the liver
(Figures 2C and 2D).
Taken together, these results indicate that MyD88 signaling in
B cells impairs control of bacterial replication and resistance of
mice to the infection upon intravenous challenge with S. typhi-
murium. This may involve an inhibitory effect of MyD88-signaling
in B cells on the protective immune response.MyD88 Signaling in B Cells Inhibits Innate Immunity
to Salmonella
The higher bacterial loads in B-WTmice at days 4 and 6 p.i. sug-
gested that MyD88 expression in B cells inhibited innate mech-
anisms of immune protection. We thus analyzed innate
responses in spleens at early time points (days 1 and 2 p.i.),
when the different groups of mice still carried similar numbers
of virulent S. typhimurium (SL1344). In addition, we analyzedovember 24, 2010 ª2010 Elsevier Inc. 779
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Figure 3. Suppression of Neutrophil and NK Cell Responses by MyD88 Expression in B Cells
B-WT, B-Myd88/, C57BL/6, and Myd88/ mice were infected either with 106 attenuated (SL7207) or with 100 virulent (SL1344) Salmonella.
(A) The top panel shows expression of CD11b and Ly6C by live spleen cells from a B-WT mouse at day 2 p.i. with SL7207. The gates used to identify neutrophils
(PMN; CD11bhiLy6C+) andmononuclear phagocytes (MP; CD11b+Ly6Chi) in infected spleens are indicated. The bottom panel shows levels of expression of Ly6G
by live PMN (orange line), MP (blue line), and CD11bLy6C cells (black line).
(B) The left panel shows the total numbers of PMNper spleen in B-WT and B-Myd88/mice infected with SL7207. The right panel shows the frequency of splenic
TNF-a-producing PMN in these chimera mice infected with SL1344. For this analysis, splenocytes were restimulated for 6 hr with heat-killed Salmonella and
stained for CD11b, Ly6C, Ly6G, and intracellular TNF-a.
(C) Numbers of PMN per spleen in C57BL/6 and Myd88/ mice infected with SL7207.
(D) The top panel shows expression of DX5 and TCRb by live spleen cells from a B-WT mouse at day 2 p.i. with SL7207. NK cells were identified as DX5+TCR-
b cells. The bottom panel shows production of IFN-g by NK cells after restimulation of splenocytes with heat-killed Salmonella for 6h.
(E) Absolute numbers of IFN-g-producing NK cells per spleen in B-WT and B-Myd88/ mice infected with SL7207 (left panel) or virulent SL1344 (right panel)
Salmonella.
(F) Absolute numbers of splenic IFN-g-producing NK cells per spleen in C57BL/6 and Myd88/ mice infected with SL7207.
(A–F) Data shown are pooled from two independent experiments (12 mice per group per time point). Mice were analyzed individually. Graphs showmean ± SEM.
*p < 0.05. **; p < 0.01; ***p < 0.0001.
See also Figure S2.
Immunity
Suppressive Roles of MyD88 Signaling in B Cellsinnate responses inmice infected with an attenuated S. typhimu-
rium strain (SL7207).
Upon infection with S. typhimurium, neutrophils, mononuclear
phagocytes, and DCs are rapidly recruited to sites of bacterial
replication where they contribute to containment of the infection
(Tam et al., 2008). We first monitored the responses mediated
by CD11bhiLy6C+Ly6Ghi neutrophils and CD11b+Ly6ChiLy6G
mononuclear phagocytes (Figure 3A) (Kang et al., 2008). Accu-
mulation of neutrophils was substantially higher in spleens of
B-Myd88/ mice than in B-WT mice after infection with attenu-780 Immunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc.ated Salmonella, whereas the two groups of mice carried similar
numbers of bacteria (Figure 3B; Figure S2A and Table S1).
Notably, we also detected a heightened accumulation of
neutrophils in livers of infected B-Myd88/ mice compared to
B-WT mice (Figure S2B). B-Myd88/ mice also developed an
enhanced neutrophil response after infection with virulent
Salmonella, as shown by a higher frequency of TNF-a-producing
neutrophils compared to B-WT mice (Figure 3B), whereas in this
case the numbers of neutrophils in the spleens were comparable
in the two types of mice (Figure S2C). We deduce from these
Immunity
Suppressive Roles of MyD88 Signaling in B Cellsobservations that B cells activated via MyD88-dependent path-
ways suppress neutrophil-mediated protection. Notably, MyD88
signaling in B cells did not alter the numbers of either mononu-
clear phagocytes or DCs (CD11chi cells) (Figures S2D and
S2E). In contrast, responses of neutrophils, mononuclear phago-
cytes, and DCs were severely impaired inMyd88/mice at day
4 p.i. (Figure 3C; Figures S2D and S2E). Thus, MyD88 controlled
the accumulation of DCs and mononuclear phagocytes in
infected spleens without a contribution from B cells, whereas
the response of neutrophils was counterregulated by MyD88
expression in B cells.
During Salmonella infection, NK cells are the first source of the
essential macrophage-activating cytokine IFN-g (Hess et al.,
1996). Remarkably, B-Myd88/ mice had substantially more
IFN-g-producing NK cells than B-WT mice at day 4 p.i. with
attenuated Salmonella, whereas absolute numbers of NK cells
were similar (Figures 3D and 3E; Table S1; data not shown). Like-
wise, stronger NK cell responses were observed in B-Myd88/
mice than in B-WT mice after infection with virulent Salmonella
(Figure 3E). Thus, MyD88 signaling in B cells results in inhibition
of the NK cell response. InMyd88/mice, the NK cell response
was severely impaired at days 4 and 21 p.i. (Figure 3F). Collec-
tively, our observations reveal an inhibitory circuit linking
MyD88 expression in B cells with innate immune defenses medi-
ated by neutrophils and NK cells.
MyD88 Signaling in B Cells Suppresses Inflammatory
T Cell Responses
Inflammatory CD4+ T cell responses play a crucial role in
protection from Salmonella infection (Hess et al., 1996). Thus, we
assessed T cell immunity in B-WT, B-Myd88/, C57BL/6, and
Myd88/mice after i.v. infection with attenuatedS. typhimurium.
At day 10 p.i., Salmonella-specific IFN-g- and TNF-a-
producing CD4+ T cells were detected in comparable numbers
in B-WT and B-Myd88/ mice (Figures 4A and 4B). In B-WT
mice, these responses were maintained to a similar degree until
day 21. In contrast, in B-Myd88/ mice the numbers of IFN-g-
and TNF-a-expressing CD4+ T cells doubled between days 10
and 21 p.i. (Figures 4A and 4B; Table S1). Thus, MyD88 signaling
in B cells resulted in selective inhibition of the expansion of
the inflammatory CD4+ T cell population. Similarly, spleens
of infected B-Myd88/ mice accumulated significantly more
IFN-g-producing CD8+ T cells compared to B-WT mice (Fig-
ure 4C; Table S1). As expected, Myd88/ mice had fewer
IFN-g- and TNF-a-producing CD4+ T cells as well as fewer IFN-
g-producing CD8+ T cells than control C57BL/6 mice at day
21 p.i. (Figures 4A–4C). Of note, we did not detect any IL-17-ex-
pressing CD4+ T cells, implying a minor role of this cytokine
during Salmonella infection (data not shown), in agreement
with others (Schulz et al., 2008). In conclusion, these data imply
that the balance between MyD88 signaling in B cells and in other
cells determines the intensity of protective inflammatory T cell
responses during the course of Salmonella infection in wild-
type mice.
MyD88 Signaling in B Cells Accelerates
the Development of Humoral Immunity
Because the proposed function of intrinsic MyD88 signaling in
B cells is the amplification of antibody responses, we comparedIhumoral immunity in B-Myd88/ and B-WT mice after infection
with attenuated Salmonella.
Rapid differentiation of activated B cells into short-lived
plasma cells is a hallmark of humoral immunity. We found that
accumulation of splenic CD138+ plasma cells peaked at day
4 p.i. in B-WT mice and then declined to preinfection numbers
by day 62 (Figure 4D). In contrast, B-Myd88/ mice developed
a delayed response, which was less intense and never reached
the amount observed at day 4 in B-WT mice (Figure 4D).
We then assessed germinal center (GC) development, a T cell-
dependent process of B cell activation. Histological analysis
revealed GCs in both B-WT and B-Myd88/ mice at day
10 p.i., although they were apparently smaller in the B-Myd88/
mice (Figure 4E). Supporting this observation was the fact that
spleens from infected B-Myd88/ mice had lower frequencies
of GL7+Fas+ GC B cells compared to B-WT mice (Figure 4F).
GC B cells give rise to long-lived BM plasma cells, which can
maintain specific antibody responses for several years (Rad-
bruch et al., 2006). Accumulation of plasma cells in BM became
evident at day 62 p.i. (Figure 4G). At this time point, B-Myd88/
mice had markedly fewer BM plasma cells than B-WT mice (Fig-
ure 4G). In line with this finding, BM cells from B-Myd88/-
infected mice produced fewer antibodies than those from B-
WT mice after in vitro culture (data not shown). Thus, MyD88
signaling in B cells is important for the establishment of the BM
pool of antibody-secreting plasma cells. It is yet unclear whether
this defect is compensated by heightened accumulation of
plasma cells in different tissues.
Subsequently, we compared antibody responses in B-
Myd88/ mice and B-WT mice. We first analyzed natural anti-
body titers in naivemice. Consistent with published data, relative
titers of both total and Salmonella-specific natural IgM were
reduced in naive B-Myd88/ mice compared to B-WT mice
(Figure S3A) (Barr et al., 2009). After S. typhimurium infec-
tion, specific IgM and IgG responses were initially lower in
B-Myd88/ than in B-WT mice, but these defects were no
longer apparent at 4 weeks p.i. (Figure 4H). We then quantified
the various IgG isotypes produced upon infection. B-Myd88/
mice showed trends for increased IgG1, and decreased IgG3
titers compared to B-WT mice, but these differences were not
statistically significant (Figure S3B). The two types of mice
made similar IgG2b and IgG2c responses (Figure S3B). Our
data indicate that MyD88 signaling in B cells can facilitate the
formation of plasma cells and germinal center B cells and accel-
erate the production of specific antibodies (Table S1). However,
most of the observed differences were only transient and
modest.
B Cell-Derived IL-10 Inhibits Immunity to Salmonella
We have previously found that in EAE, the suppressive function
of B cells on T cell-mediated immunity depends on both MyD88
and IL-10 (Fillatreau et al., 2002; Lampropoulou et al., 2008). We
therefore asked whether B cells counterregulate cellular mecha-
nisms of protective immunity via IL-10 during Salmonella
infection.
Salmonella can directly induce IL-10 production by B cells
in vitro via a mechanism involving TLR2 and/or TLR4 (but not
TLR9) and MyD88 (Figure S4A). Notably, DCs produced little
IL-10 upon coculture with Salmonella, indicating the uniquenessmmunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc. 781
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Figure 4. MyD88 Signaling in B Cells Suppresses Inflammatory T Cell Responses and Accelerates Humoral Immunity to Salmonella
B-WT, B-Myd88/, C57BL/6, and Myd88/ mice were infected i.v. with 106 CFU Salmonella (SL7207). At indicated time points, splenocytes were isolated,
restimulated for 6 hr with heat-killed Salmonella, and stained for CD4, CD8, and intracellular cytokines.
(A and B) show total numbers of IFN-g- and TNF-a-expressing CD4+ T cells per spleen in B-WT and B-Myd88/mice (left panel) and in C57BL/6 andMyd88/
mice (right panel).
(C) Total numbers of IFN-g-expressing CD8+ T cells per spleen in B-WT and B-Myd88/ mice (left panel) and in C57BL/6 and Myd88/ mice (right panel).
(D) Shown on the left are splenic plasma cells (PCs) identified by flow cytometry as CD138+MHC-IIloB220+ cells (gated on live B220+ cells; plot from B-WT at
day 4 p.i.). Shown on the right is quantification of PC in spleens of B-WT (black bars) and B-Myd88/ (white bars) mice at indicated time points after infection.
(E) Staining of splenic germinal centers (GCs) by immunofluorescence with PNA (peanut agglutinin; red) and B220 (green) in mice at day 10 p.i.
(F) As shown in the top panel, splenic GC B cells were identified by flow cytometry as GL7+Fas+B220+ (gated on live B220+ cells; B-WT mouse at day 10 post-
infection). The bottom panel shows the frequency of GC cells among B cells in spleen of B-WT (black bars) and B-Myd88/ (white bars) mice at indicated time
points after infection.
(G) As shown on the left, BM cells were stained as in (A) to identify CD138+MHC-IIlowB220+ PC (gated on live B220+ cells, B-WT mouse at day 62 p.i.). Shown on
the right are numbers of PCs in BM (two femurs and one tibia) in B-WT (black bars) and B-Myd88/ (white bars) mice at indicated time points after infection.
(H) Serum titers of Salmonella-reactive IgM (left) and IgG (right) antibodies were determined at weekly intervals in B-WT (black bars) and B-Myd88/ (white bars)
mice by ELISA. Pooled data from three independent experiments, with 15 mice per group per time point, are shown.
(A–C) Data are from three independent experiments for B-WT and B-Myd88/ mice (15 mice per group per time point) and two independent experiments for
C57BL/6 and Myd88/ mice (ten mice per group per time point).
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Figure 5. IL-10 Expression in B Cells during Salmo-
nella Infection
(A and B) IL-10.eGFP and control C57BL/6 mice were
infected i.v. with 106 Salmonella (SL7207). On day 1 p.i.,
live splenocytes were stained ex vivo for CD19 and
CD138 without prior stimulation. Data are representative
of three independent experiments.
(A) Expression of eGFP by CD19-gated live splenocytes
from naive and infected IL-10.eGFP mice and infected
C57BL/6 mice. Numbers indicate percentages of eGFP-ex-
pressing cells among CD19+ B cells.
(B) Dot plots gated on CD19+ cells show eGFP expression
by CD138+ cells. Histogram shows expression of eGFP by
CD138+CD19+ cells from naive and infected IL-10.eGFP
mice.
(C) Relative Il10 mRNA expression by CD138+CD19+ and
CD138CD19+ cells sorted from splenocytes of C57BL/6
mice on days 1 and 3 p.i. with 106 attenuated Salmonella.
Il10 mRNA expression amounts were calculated relative
to B cells from naive mice. Pooled data from two indepen-
dent experiments are shown. Cells were sorted from
a pool of six and mice mice on days 1 and 3, respectively,
for each experiment. Graphs show the mean ± SEM.
(D) Frequency of eGFP+ among CD138+CD19+ cells (left)
and absolute numbers of GFP+CD138+CD19+ cells (right)
in spleen at indicated time-points after infection of
IL-10.eGFP or C57BL/6 mice with 106 or 107 attenuated
Salmonella (SL7207). Shown are pooled data from two
independent experiments (six mice per group per time
point). Graphs show the mean ± SEM.
(E) Numbers of CD138+CD19+ cells in spleen from B-WT
and B-Myd88/ chimera mice at the indicated time-points
after infection with 106 attenuated Salmonella.
(F) Relative Il10 mRNA expression by CD138+CD19+ and
CD138-CD19+ cells sorted from splenocytes of B-WT and
B-Myd88/ mice on days 1 and 3 p.i. with 106 attenuated
Salmonella. Il10 mRNA expression was calculated relative
to B cells from naive B-WT mice. Shown is pooled data
from two independent experiments. Cells were sorted
from a pool of six and 4 mice on days 1 and 3, respectively,
for each experiment. Graphs show mean ± SEM. ***p <
0.0001.
See also Figure S4.
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Suppressive Roles of MyD88 Signaling in B Cellsof this B cell response (data not shown). To examine the devel-
opment of IL-10-producing B cells during the course of Salmo-
nella infection in vivo, we used an IL-10.eGFP reporter mouse
strain (called B-Green mouse), in which the eGFP coding
sequence was gene-targeted to the Il10 locus just downstream(D–G) Data shown are pooled from two independent experiments, with 10–16 mice per group per ti
Mice were analyzed individually. Graphs show the mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.
See also Figure S3.
Immunity 33, 777–of the translation stop (Figure S4B). Remarkably,
a population of eGFP+ B cells could be detected
in B-Greenmice as early as day 1 p.i. (Figure 5A).
These cells characteristically expressed the
marker CD138, which is classically associated
with plasmablast and plasma cell differentiation
but can also be upregulated on other types of
activated B cells (Figure 5B). In contrast, we
could not detect induction of eGFP expression
in CD19 cells or in CD19+CD138 B cells at
this early time point p.i. (Figures S4C and S4D). In order to verify
that Salmonella infection results in rapid development of Il10-
expressing CD138+ B cells, we isolated CD138+ and CD138
B cells from C57BL/6 mice at days 1 and 3 p.i. (Figure S4E)
and quantified their Il10 mRNA content. As expected, Il10me point.
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Figure 6. B Cells Suppress Immunity to
Salmonella Infection via IL-10
(A) Survival of B-Il10/ (n = 8) and control chimera
with wild-type B cells (n = 9) after i.v. infection with
100 CFU virulent Salmonella (SL1344).
(B) Liver histochemistry of total infiltrating cells
(H&E; hematoxylin and eosin), T cells (CD3) and
neutrophils (MPO7; myeloperoxidase 7) at day 6
p.i. A 1003 magnification of the original image is
shown.
(C) Number of the inflammatory foci per liver
section at day 6 p.i. (B-WT, n = 4; B-Il10/,
n = 7). Representative aggregates of MPO7+
neutrophils are encircled.
(D) Total numbers of TNF-a-producing PMN per
spleen in B-WT and B-Il10/ mice infected with
SL1344 (left panel) or SL7207 (right panel) at indi-
cated time-points p.i. For this analysis, spleno-
cytes were restimulated for 6 hr with heat-killed
Salmonella and stained for CD11b, Ly6C, and
intracellular TNF-a.
(E) Frequency of IFN-g-producing NK cells per
spleen in B-WT and B-Il10/ mice infected with
SL1344 or SL7207. For this analysis, splenocytes
were restimulated for 6 hr with heat-killed Salmo-
nella and stained for TCR-b, DX5, and intracellular
IFN-g.
(F) B-Il10/ and control chimera mice were
infected i.v. with 106 Salmonella (SL7207). At indi-
cated time points, splenocytes were isolated,
restimulated for 6 hr with heat-killed Salmonella
(HKS), and stained for CD4 and intracellular
IFN-g and TNF-a. Mice were analyzed individually.
Left panels show an example of flow cytometry
results for a BW-T and a B-Il10/mouse analyzed
at day 21 p.i. The ‘‘unstimulated’’ plots correspond
to unstimulated cells from the B-Il10/ mouse.
Numbers indicate percentages of cytokine-
producing cells among CD4+ T cells. Right panels
show absolute numbers of IFN-g+ (top), and
TNF-a+ (bottom) CD4+ T cells per spleen. Graphs
show the mean ± SEM. *p < 0.05 and **p < 0.01.
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Suppressive Roles of MyD88 Signaling in B CellsmRNA was strongly upregulated in CD138+ cells (but not in
CD138 cells) both at days 1 and 3 p.i. (Figure 5C). We then
used the B-Green reporter strain to characterize the dynamic
of this B cell response during the course of Salmonella infection.
Notably, the frequency of GFP-expressing cells among CD138+
B cells was maximum at day 1 p.i., when it was proportional to
the number of bacteria administered and decreased thereafter
(Figure 5D). Approximately 50% of splenic CD19+CD138+ cells
expressed eGFP at 24 hr p.i. with 107 colony forming unit
(CFU) Salmonella (Figure 5D). Remarkably, this early response
was markedly diminished in B-Myd88/ mice compared to784 Immunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc.g
w
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B
dB-WTmice. In particular, lack ofMyd88 in
B cells resulted in dramatically impaired
development of CD138+CD19+ B cells
(Figure 5E). From these experiments, we
conclude that Salmonella infection results
in vivo in the rapid accumulation of IL-10-
expressing CD19+CD138+ B cells in
spleen via a MyD88-dependent pathway.To assess the role of IL-10 expression by B cells in vivo, we
enerated B-Il10/ mice by reconstituting irradiated JHT mice
ith a mixture of BM cells from JHT mice (80%) and Il10-defi-
ient mice (20%). Control chimera was obtained by reconstitut-
g irradiated JHT mice with BM cells from C57BL/6 mice (80%)
nd Il10/ mice (20%). Remarkably, B-Il10/ mice showed
proved survival after infection with virulent Salmonella, indi-
ating that IL-10 production by B cells inhibited protection (Fig-
re 6A). The similar improvement of survival seen in infected
-Il10/ and B-Myd88/ mice, together with the impaired
evelopment of IL-10-expressing B cells in B-Myd88/ mice,
Immunity
Suppressive Roles of MyD88 Signaling in B Cellssuggested to us that IL-10 could be an important mediator of the
suppression resulting from intrinsic MyD88 signaling in B cells
during Salmonella infection. To examine this notion further, we
characterized the innate and adaptive immune responses of
B-Il10/ mice infected with Salmonella. Notably, lack of IL-10
in B cells was associated with heightened infiltration of immune
cells in infected livers, so that B-Il10/ mice had 2-fold more
inflammatory foci than B-WT mice at day 6 p.i. (Figures 6B and
6C), as previously seen for B-Myd88/ mice (Figure 2C). Simi-
larly, B-Il10/ mice displayed enhanced neutrophil and NK
cell responses after infection with either attenuated or virulent
Salmonella (Figures 6D and 6E). We also found, as previously
described during EAE (Fillatreau et al., 2002), that IL-10 produc-
tion by B cells strongly suppressed the specific CD4+ T cell
response to Salmonella: B-Il10/ mice had more IFN-g-
producing CD4+ T cells and more TNF-a-producing CD4+
T cells than control mice at day 21 p.i. (Figure 6F). Thus, the regu-
latory functions of B cells during Salmonella infection involve
both MyD88 and IL-10, as previously observed in EAE (Fillatreau
et al., 2002; Lampropoulou et al., 2008). Considering that Salmo-
nella triggers the development of IL-10-producing B cells in
a MyD88-dependent manner, these results suggest that IL-10
mediates at least part of the suppressive functions resulting
from MyD88 signaling in B cells. However, MyD88-activated
B cells may also exert suppressive functions via additional
mechanisms.
Vaccination Fully Protects Mice with Myd88-Deficient
B Cells from Lethal Infection
TLRs and MyD88 can promote long-lasting antibody responses
and T cell memory, suggesting a critical role for this pathway in
vaccine efficacy (Krieg, 2007; Pasare and Medzhitov, 2004).
However, we found that MyD88 expression in B cells can lead
to inhibition of protective cellular immunity toward Salmonella
infection. Thus, we examined whether MyD88 signaling in B cells
affects the protective efficacy of a live-attenuated Salmonella
vaccine.
B-WT and B-Myd88/mice were vaccinated with attenuated
Salmonella and then challenged with virulent Salmonella 90 days
later, a time point when the attenuated bacteria had been com-
pletely cleared (Figure S2A). MyD88 signaling in B cells pro-
foundly affected the protection afforded by the vaccine. Vacci-
nated B-Myd88/ mice were completely protected against
virulent S. typhimurium, demonstrating a 100% survival after
2 months (Figure 7A). In contrast, protection was only partial in
B-WT mice, which started to succumb at day 7 with a 50%
survival rate after 60 days (Figure 7A). Thus, the efficacy of the
live-attenuated vaccine is impaired as a result of MyD88 expres-
sion in B cells.
To identify the protective mechanisms regulated by MyD88-
signaling in B cells during this rechallenge experiment, we
infected vaccinated mice with attenuated Salmonella (SL7207)
and analyzed innate and adaptive immune responses 5 days
later, when bacterial loads were similar in spleens and livers of
B-WT and B-Myd88/ mice (Figure S5A). Because the protec-
tion afforded by the attenuated Salmonella vaccine involves anti-
body production (Mastroeni et al., 1993; Mittru¨cker et al., 2000),
we measured amounts of Salmonella-reactive antibodies in
serum of vaccinated mice before and after rechallenge. SerumIantibody titers were comparable at day 90 in vaccinated B-WT
and B-Myd88/ mice, and they were not significantly modu-
lated at day 5 after reinfection (Figure S5B). We then examined
whether MyD88 signaling in B cells influenced memory T cell
responses occurring in spleen and BM (Tokoyoda et al., 2009).
Salmonella-reactive IFN-g-, TNF-a-, and IL-10-producing CD4+
and CD8+ T cells were present in equal numbers in spleen and
BM of B-WT and B-Myd88/ mice at day 90 postvaccination
(Figures 7B and 7C; Figure S6C). Anamnestic T cell responses
were also similar at day 5 after rechallenge in B-WT and
B-Myd88/mice, as shown by analyzes of production of IFN-g,
TNF-a, or IL-10 by CD4+ and CD8+ T cells from spleen and BM
(Figures 7B and 7C; Figure S6C). T cell responses were not
detected at day 5 p.i. in naive mice (data not shown). Thus,
MyD88 signaling in B cells does not appear to modulate the
formation or the reactivation of memory T cells at the time points
analyzed. This is consistent with our observations in naive
chimera mice, in which differences in T cell responses were
only observed between B-WT and B-Myd88/ mice at day
21 p.i. (Figures 4A–4C).
In contrast, vaccinated B-Myd88/ mice displayed substan-
tially higher innate responses than vaccinated B-WT mice upon
rechallenge (Figures 7D and 7E). Vaccinated B-Myd88/ mice
harbored more neutrophils in spleen and liver than B-WT mice
at day 5 after rechallenge, and markedly more TNF-a-producing
neutrophils in spleen, whereas these parameters were similar
in the two types of mice on day 90 (Figure 7D). Similarly,
B-Myd88/ mice accumulated more NK cells in livers than
B-WT mice (Figure 7E). Thus, as seen for naive mice, MyD88-
signaling in B cells exerts an early regulatory effect on innate
immune responses mediated by neutrophils and NK cells during
rechallenge of vaccinated mice.
We then examined whether this B cell-mediated suppression
represented a major contribution of the B cell compartment
during rechallenge of vaccinated mice. To this end, we per-
formed vaccination and rechallenge experiments with wild-
type C57BL/6 mice treated after vaccination, 1 week prior to
rechallenge, with a B cell-depleting aCD20 antibody. Remark-
ably, this treatment improved the survival of vaccinated mice
(Figure 7F), confirming the important role of B cell-mediated
regulation during Salmonella infection in wild-type mice. Thus,
a major function of the B cell compartment during reinfection
of vaccinated mice is to regulate the protective innate response
against Salmonella.
DISCUSSION
The signaling adaptor protein MyD88 is critical for effective host
defense against infections (von Bernuth et al., 2008). However,
we demonstrate in this study that MyD88 expression in B cells
markedly inhibits protective immunity during systemic Salmo-
nella infection. Deficiency of Myd88 in B cells improved the
control of the infection and sustained the survival of the infected
mice. Remarkably, vaccination afforded complete protection
against infection in mice with a B cell-specificMyd88 deficiency,
but only partial protection in control mice. Our data demonstrate
that one of themajor consequences ofMyD88 signaling in B cells
during infection with an intracellular bacterium is the suppression
of innate immunity. Furthermore, using a B cell-depletingmmunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc. 785
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Figure 7. Vaccination Fully Protects Mice with Myd88-Deficient B Cells from Virulent Salmonella Infection
(A) Survival of vaccinated B-WT (black squares; n = 22) and B-Myd88/ (white squares, n = 19) mice following i.v. challenge with virulent Salmonella SL1344.
Mice were vaccinated i.v. with 106 attenuated Salmonella (SL7207) and challenged 90 days later with 100 CFU SL1344.
Results are pooled from two independent experiments; **p < 0.01.
(B–E) B-WT (black bars) and B-Myd88/ (white bars) mice were vaccinated i.v. with 106 Salmonella (SL7207). After 90 days, mice were either re-challenged with
106 SL7207 i.v. (+) and analyzed 5 days later, or analyzed without rechallenge (). Splenocytes, BM cells, and liver leukocytes were isolated from individual mice,
restimulated for 6 hr with heat-killed Salmonella, and stained for T cell, PMN, and NK cell markers together with intracellular cytokines. Pooled data from three
independent experiments (B-WT mice, n = 7; B-Myd88/, n = 8) are shown. Graphs show the mean ± SEM; *p < 0.05.
(B) Total numbers of IFN-g- and TNF-a-producing CD4+ T cells in spleen (left) and BM (two femurs and two tibias) (right) in non-rechallenged (), and rechallenged
(+) mice.
(C) Total numbers of IFN-g-producing CD8+ T cells in spleen and BM, as described in (B).
(D) Total numbers of PMN and TNFa-producing PMN in spleen (left panel) and liver (right panel). PMN were defined as in Figure 3.
(E) Total numbers of NK cells in liver. NK cells were defined as in Figure 3.
(F) Survival of C57BL/6 mice vaccinated with 106 attenuated Salmonella (SL7207) and rechallenged 90 days later with 100 CFU virulent Salmonella (SL1344).
A group of vaccinated mice received a single dose of B cell-depleting CD20 antibody 1 week prior to rechallenge. Shown are pooled data from two independent
experiments (untreated group, n = 11; treated group, n = 11); *p < 0.05.
See also Figure S5.
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Suppressive Roles of MyD88 Signaling in B Cellsantibody, we could show that B cells limit the resistance of vacci-
nated wild-type mice to rechallenge.
We show that Salmonella infection results in the rapid differen-
tiation of IL-10-expressing B cells in spleens of infected mice.
This response was already detected at 24 hr p.i. and persisted
for at least 3 days. At these early time points Il10 expression
was restricted to B cells expressing the plasmablast and plasma
cell marker CD138, as revealed using IL-10.eGFP reporter786 Immunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc.B-Green mice, and real-time PCR on cells isolated from infected
wild-typemice. IntrinsicMyD88-signaling in B cells was essential
for the optimal development of IL-10-producing CD19+CD138+
B cells, being absolutely required for the expansion of the
CD19+CD138+ B cell subset during the early course of the
infection. Altogether, these data position IL-10-producing B cells
at the interface between the adaptive and the innate immune
systems. Indeed, the rapidity of this response, as well as its
Immunity
Suppressive Roles of MyD88 Signaling in B Cellsdependence on the signaling adaptor MyD88 are features char-
acteristic of innate immunity. Furthermore, we observed that
IL-10 produced by B cells regulates innate pathways involving
neutrophils and NK cells. In vaccinated mice, such modulation
of the innate immune system was associated with a marked
inhibition of host resistance to reinfection. Thus, our observa-
tions suggest an unexpected regulatory role of IL-10-producing
CD138+CD19+ B cells on innate immunity. Are these cells anti-
body-secreting plasmablasts or plasma cells? It will be impor-
tant to further characterize these cells and to delineate their
relationship with marginal zone B cells that express high
amounts of TLRs, that rapidly secrete IL-10 upon TLR triggering,
and that are among the first cells to encounter antigens from the
blood.
Neutrophils provide an important first line of defense against
Salmonella (Conlan, 1997). Soon after infection, they accumulate
in spleen and liver, where they lyse infected cells, and prevent
the spread of the bacteria (Conlan, 1996). Depletion of neutro-
phils results in dramatic expansion of Salmonella and dissemina-
tion of the infection to brain, lungs, and kidneys (Conlan, 1997).
Remarkably, we found that neutrophils accumulatedmore effec-
tively in spleens and livers of infected B-Myd88/ and B-Il10/
mice than of B-WTmice. MyD88 signaling in B cells also resulted
in inhibition of this innate response upon rechallenge of vacci-
nated mice. Similarly, B cell-deficient mice mounted increased
neutrophil responses after infection with Francisella tularensis,
Chlamydophila abortus, Mycobacterium tuberculosis, or Leish-
mania donovani, which can all signal via TLRs andMyD88 (Bosio
and Elkins, 2001; Buendı´a et al., 2002; Buendı´a et al., 2009;
Maglione et al., 2007; Smelt et al., 2000). Although the signals
driving B cell-mediated inhibitions of neutrophils were not
defined in these studies, our observations together with these
data suggest a general role for MyD88 signaling in B cells and
for IL-10 in the regulation of neutrophil responses. Previous
studies showed that IL-10 can regulate neutrophil responses
during infections (Dai et al., 1997).
Control of Salmonella infection critically depends on IFN-g
(Hess et al., 1996; Spo¨rri et al., 2006). At early stages of infection,
NK cells are the major source of this cytokine. NK cell activation
was severely impaired inMyd88-deficient mice, possibly due to
the lack of intrinsic MyD88 signaling in NK cells (Spo¨rri et al.,
2006). Unexpectedly, we found that B-Myd88/ and B-Il10/
mice developed stronger NK cell responses than B-WT mice
after Salmonella infection. Such regulation was also observed
upon rechallenge of vaccinated B-WT and B-Myd88/ mice.
Similarly, mice lacking B cells showed increased NK cell activity
after LCMV infection (Bru¨ndler et al., 1996). Such increased NK
cell responses could result from heightened DC activation given
that DCs can provide key signals for NK cell responses (Hochw-
eller et al., 2008; Kang et al., 2008; Lucas et al., 2007). After Lis-
teria monocytogenes infection, DCs recruit NK cells into foci
where bacteria are trapped and activate them locally to produce
IFN-g via IL-12 and IL-18 (Kang et al., 2008). During Salmonella
infection, the early production of IFN-g also depends on IL-12
and IL-18 (Mastroeni et al., 1999; Mastroeni et al., 1996).
Notably, B cells activated via MyD88 can directly suppress via
IL-10 the provision of these NK cell-activating factors by DCs
(Lampropoulou et al., 2008; Moulin et al., 2000). It is therefore
plausible that an altered interaction between B cells and DCsIunderlies the increased NK cell responses in B-Myd88/
mice. Others have recently shown that Treg cells can also
suppress NK cell activity (Feuerer et al., 2009). However, it is
unlikely that during Salmonella infection B cells could regulate
NK cells via Treg cells given that Treg cell inactivation had no
effect on survival of the infected mice.
We found here that B-Myd88/ mice mounted stronger Th1
cell responses to Salmonella than B-WT mice. Intriguingly, B
cells can also regulate T cell responses to self-antigens upon
activation via MyD88, suggesting that MyD88 signaling in B cells
operates within a general circuit of immune regulation (Lampro-
poulou et al., 2008; Skupsky et al., 2007; Zambidis et al., 1997).
Our data indicate that this inhibitory function of B cells involves
IL-10 given that Salmonella stimulates the accumulation of
IL-10-producing B cells in a MyD88-dependent manner, and
mice lacking IL-10-producing B cells also display enhanced
inflammatory T cell responses during this bacterial infection, as
previously observed in EAE (Fillatreau et al., 2002). It is likely
that DCs are a major target of this suppression because IL-10
produced by TLR-activated B cells can inhibit the capacity of
DCs to drive Th1 cell differentiation in vitro and in vivo (Lampro-
poulou et al., 2008; Sun et al., 2005). In addition, adoptive trans-
fer experiments have shown that LPS-activated B cells can
suppress T cell immunity via a mechanism independent of
IL-10 but requiring expression of MHC-II and CD86 by the B cells
(El-Amine et al., 2000; Litzinger et al., 2005). The role of this alter-
native mechanism remains to be tested during Salmonella
infection.
The suppressive effects resulting from MyD88-signaling in
B cells can be viewed as paradoxical considering the important
roles of MyD88 and B cells for host defense. However, we
recently proposed a model explaining how they could confer
advantageous properties to the immune system by granting
improved robustness of microbial sensing, and accelerated
kinetic of induction of immunity, while preventing excessive
tissue inflammation (Lampropoulou et al., 2010). This is possible
because, as shown by our data,MyD88 signaling in B cells is part
of a negative feed-forward loop controlling the responses trig-
gered by MyD88 signaling in other cells (Lampropoulou et al.,
2010; Lampropoulou et al., 2008; Sun et al., 2005). Notably,
such negative feed-forward loops are one of the principal mech-
anisms for increasing robustness of biological systems toward
external variation (Kitano, 2004). In the case of infection, muta-
tions reducing the binding affinity of pathogen-associated
molecular patterns (PAMPs) for the stimulatory pattern recogni-
tion receptors (PRRs) could facilitate pathogen escape. How-
ever, if PRRs can transmit both stimulatory and inhibitory signals,
reduction in the affinity of the PAMP for the PRR would be
compensated by a proportional diminution of the inhibitory
signal, so that an effective immune response could still develop,
as expected from a robust system. In addition, experiments
and mathematical modeling have demonstrated that inhibitory
feed-forward loops allow accelerated biological responses com-
pared to simple stimulatory loops (Alon, 2007). The importance
of rapid immune responses for the adequate control of patho-
gens is unambiguously demonstrated by the improved protec-
tion conferred by immunological memory and vaccines. Thus,
it is not surprising to find that such loops, which are widely
used in other biological and engineering systems, also contributemmunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc. 787
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Suppressive Roles of MyD88 Signaling in B Cellsto immune regulation (Alon, 2003). According to such model,
suppression should be higher when the system is exposed
to stronger stimulatory signals. Our finding that the amount of
IL-10-producing B cells in spleens of infected mice was propor-
tional to the number of bacteria administered is consistent with
this notion.
In conclusion, we have identified an unexpected function of
MyD88-signaling in B cells—the limitation of cell-mediated
immune responses during bacterial infection—and confirmed
its amplifying role in humoral immunity. Notably, we found that
MyD88 signaling in B cells results in downmodulation of three
crucial arms of cellular immunity: neutrophils, NK cells, and
inflammatory T cells. It will be important to determine whether
similar negative feed-forward loops, which can sustain the
dynamics and the robustness of immunity, also operate in other
systems of pathogen recognition. Unraveling the complexity of
such multicellular networks is likely to facilitate the design of
novel immune intervention strategies against pathogens.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6,Myd88/, Il10/, Tlr9/, Tlr2/Tlr4/, and JHT (Gu et al., 1993)
mice were bred under specific pathogen-free conditions. Chimera were made
as described (Fillatreau and Gray, 2003). Experiments were performed in
accordance with French, German, Portuguese, and Russian authorities.
Generation of B-Green IL-10iRESeGFP Gene-Targeted Mouse
The long homology arm of the targeting construct comprised the third to fifth
exons of the Il10 gene (Figure S4B). An IRES-eGFP construct followed by loxP-
flanked neomycin (neoR) selection cassette was introduced just downstream
of the translational stop. As a short homology arm we used the upstream 30
untranslated region of IL-10’s fifth exon along with the endogenous polyade-
nylation sequence. A herpes simplex thymidine-kinase expression cassette
was cloned to the 30 flank of the targeting construct as a counter-selectable
marker for transgene-integration. E14.1 ESCs were electroporated with the
linearized targeting construct and positively and negatively selected with
G418 and gancyclovir, respectively. G418 and gancyclovir double-resistant
ESC clones were screened for correct integration by Southern blotting and
PCR. Finally, targeted clones were injected into C57BL/6 blastocysts.
Chimeric males were bred to wild-type C57BL/6 mice, and offspring screened
by PCR for the mutated allele. Deletion of the neomycin-resistant gene using
Cre-mediated recombination of flanking loxP sites in the targeted locus was
achieved by crossing with a Cre deletor transgenic line (Lewandoski et al.,
1997).
Bacterial Infections
Salmonella typhimurium strains (virulent SL1344; attenuated aroA SL7207)
were used as described (Mittru¨cker et al., 2000). Mice were infected i.v. with
1 3 106 colony-forming units (CFUs) SL7207 or 100 CFU SL1344. In vaccina-
tion and rechallenge experiments mice were first vaccinated with 13 106 CFU
SL7207 and 90 days later were rechallenged i.v. with either 100 CFUSL1344 or
13 106 CFUSL7207, as indicated. In B cell depletion experiments, vaccinated
C57BL/6 mice received a single i.v. dose of 250 mg anti-CD20 antibody (clone
18B12) 1 week prior to rechallenge with 100 CFU SL1344. The 18B12 IgG2a
anti-CD20 was a kind gift of R. Dunn and M. Kehry at Biogen Idec (Hamel
et al., 2008). Survival was recorded daily and presented as percentage of
live animals. We determined bacterial burden by plating dilutions of homoge-
nized organs on MacConkey agar plates. Heat-killed Salmonella typhimurium
(HKST) was SL1344 inactivated by incubation at 70C for 1 hr.
Histology
For immunostaining, 2- to 3-mm-thick sections of formalin-fixed, paraffin-
embedded tissue were cut, deparaffinized, and subjected to a heat-induced
epitope retrieval step. Slides were rinsed in cool running water and washed788 Immunity 33, 777–790, November 24, 2010 ª2010 Elsevier Inc.in Tris-buffered saline (pH 7.4) before incubation with primary antibodies
against CD3 (N1580, Dako, Glostrup, Denmark, dilution 1:10), B220 (eBio-
science, San Diego, CA, USA, 1:200), myeloperoxidase (A0398, Dako,
1:10000), and F4/80 (eBioscience, 1:50) for 30 min. For detection, biotinylated
donkey anti-rat or donkey anti-rabbit (Dianova, Hamburg, Germany) sec-
ondary antibodies were used, and subsequently, the streptavidin-AP kit
(K5005, Dako) was used. Alkaline phosphatase was revealed by Fast Red
as chromogen. We performed negative controls by omitting the primary
antibody.Flow Cytometry
Cells were stained as follows: After blocking of Fc receptors (2.4G2), surface
stainings were done with mAbs against B220 (RA3.6B2), CD4 (GK1.5), CD8a
(53-6.7), TCRb (H57-597), CD49b (DX-5), MHC-II (M5/114), CD138 (281-2),
Fas (CD95), Ly-77 (GL7), CD11b (M1/70), CD11c (N418/HL3), CD80 (16-
10A1), CD86 (GL1), CD1d (1B1), CD5 (53-7.3), CD21 (7G6), CD23 (B3B4),
CD44 (IM7), CD62L (MEL-14), Ly6C (AL-21), and Ly6G (1A8). Antibodies
were from BD PharMingen (San Diego, CA), eBioscience (San Diego, CA), or
Miltenyi Biotec (Bergisch Gladbach, Germany) or produced in our facility.
Dead cells were excluded with propidium iodide.
For intracellular stainings, splenocytes or BM cells were seeded at 3 3 106
cells per well in flat-bottomed 48-well plates with 1 ml RPMI 1640 (with 10%
FCS, L-glutamine, penicillin, streptomycin, and 2-ME) and restimulated with
HKST (1 3 108 bacteria/well). After 1h Golgistop (BD PharMingen) was added
in recommended amounts. The cultures were left for another 4 hr 30 min, then
surface and intracellularly stained with the Cytofix/Cytoperm kit (BD Biosci-
ences) as recommended. Antibodies were anti-IL-10 (JES5-16E3), anti-
IFN-g (XMG1.2), and anti-TNF-a (MP6-XT22); all from BD PharMingen.
Data were acquired on FACSCalibur (BD Biosciences) and analyzed with
FlowJo software (Tree Star Inc.). For FACS sorting, CD138+ and CD138
CD19+ cells were sorted from live splenocytes gated on non-CD11b/CD11c/
CD4 cell with a FACSAria II (BD Biosciences).ELISA
To measure Salmonella-specific Abs, diluted sera were incubated on 96-well
plates coated with 5 3 106 HKST/well. For measuring total Abs, plates were
coated with anti-Ig(H+L) (Southern Biotechnology Associates, Birmingham,
AL, USA). Detection was done with alkaline phosphatase-conjugated anti-
IgM and anti-IgGs Abs (Southern Biotechnology Associates).
Splenic B cells were obtained with anti-CD43 microbeads (Miltenyi Biotec),
and activated at 5 3 105 cells per well in 96-well flat-bottom plates as
described (Lampropoulou et al., 2008) with different amounts of HKST. IL-10
was measured after 3 days by cell-based ELISA, as described (Lampropoulou
et al., 2008).mRNA Expression Analysis
RNA was isolated from sorted cells with Trizol (AMS Biotechnology, Europe
Ltd.), treated with DNase (Ambion Inc.), and reverse-transcribed with the
Reverse Transcription System (Promega). Quantitative RT-PCR was per-
formed on an MX3005P QPCR System (Stratagene), with LighCycler FastStart
DNAMaster SYBRGreen I (Roche). Transcripts were quantifiedwith b-actin as
an internal standard. Forward primers (FPs) and reverse primers (RPs) were as
follows (MWG Biotech): IL-10 FP: 50-AGC CGG GAA GAC AAT AAC TG-30,
IL-10 RP: 50-CAT TTC CGA TAA GGC TTG G-30; b-actin FP: 50-TGG AAT
CCT GTG GCA TCC ATG AAA C-30, b-actin RP: 50-TAA AAC GCA GCT CAG
TAA CAG TCC-30.Alanine and Aspartate Aminotransferase Measurements
Serum samples were obtained on the indicated days, stored at 20C, and
analyzed on an automatic Roche modular analyzer (Grenzach-Wyhlen,
Germany).Statistical Analysis
Data were analyzed with an unpaired two-tailed Student’s t test. Survival
curves were compared with the log rank test.
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